Document is current
Any future updates will be listed below
-
Authors
Loor, Angelique
Mack, Kyeara N.
Bauer, David
Ingham, Aidan
Pratt, Edwin C.
Lewis, Jason S.
-
Funding
Funding for this research was provided by:
National Cancer Institute (K99 CA276804)
National Cancer Institute (R35 CA232130-04)
National Institutes of Health (S10 OD016207-01)
National Institutes of Health (P30 CA08748)
- License Information
-
More Information
Article History
Received: 23 December 2025
Accepted: 11 February 2026
First Online: 28 February 2026
Declarations
:
: Research from this manuscript with mice were conducted in accordance with IACUC guidelines under the approved protocol of Jason S. Lewis at MSKCC.
: E.C.P. and J.S.L. have authored different works on TROP-2 antibody-based PET imaging using a proprietary TROP-2.2 antibody provided by Eli Lilly and Company through a sponsored research agreement. JSL and MSKCC have a licensed patent for US11135320B2 to Clarity Pharmaceuticals. The remaining authors from MSKCC declare no additional conflicts of interest beyond the sponsored research agreement. See the funding statement for all NIH grant support.
